Zylö Therapeutics a Finalist in the Buzz of BIO Contest

Voting ends tonight for the Buzz of BIO contest, sponsored by BIO, the world's largest trade association representing biotechnology companies.  Zylö Therapeutics, which has dermatology as one of its focus areas, is a finalist in the “Pipelines of Promise” category.

Zylö’s endocannabinoid-loaded Z-pod solution, co-developed by dermatologist Adam Friedman, MD, is showing striking results in a lupus model, according to the company. Lupus affects women and people of color disproportionately, and has tragic quality-of-life ramifications.
The company also notes that its “nitric-oxide-releasing Z-pod solution is showing compelling results in an Erectile Dysfunction model where ED is secondary to prostatectomy.” They seek recognition for their technology, which “is disruptive and affordable... and we plan on keeping it that way.”

BIO says the contest provides an excellent opportunity for companies looking to make the connections needed to take their product to the next phase. One winner in each of the two categories will be chosen to receive a free company presentation at the BIO International Convention.  

The companies with the most number of votes in each category at the end of the voting period at 5pm ET March 19 will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors.

To vote:

1. Go here: https://lnkd.in/ezzymZK 

2. Complete each field 

3. Select the company you wish to vote for

4. Hit ‘submit’.